Lakewood-Amedex Biotherapeutics, Inc. ( LABT) - Key Metrics
LABT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.66 | -$1.48 | -$1.48 |
| 2026Q1 | $0 | -$1.32 | -$0.50 | -$0.50 |
| 2025Q4 | $0 | -$3.90 | -$2.21 | -$2.21 |
| 2025Q3 | $0 | -$1.37 | -$0.44 | -$0.44 |
| 2025Q2 | $0 | -$1.66 | $0 | $0 |
LABT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.29 |
| 2026Q1 | 0% | -10.81 |
| 2025Q4 | 0% | -5.54 |
| 2025Q3 | 0% | -15.78 |
| 2025Q2 | 0% | -13.03 |
LABT
Price: $0.58
52 week price:
Earnings Per Share: -2.41 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 million